Table 2 Selection criteria for study subjects.
Criterion | |
|---|---|
1 | The full-term infant was 37–40 weeks after cesarean or vaginal birth at the time of study |
2 | Free of intrauterine asphyxia, with an Apgar score > 7/min and stable vital signs within 24 h after birth |
3 | Free of complication, such as severe infections, cardiopulmonary diseases, congenital genetic diseases, or gastrointestinal malformation |
4 | Hospital stay ≥ 7 days |
5 | No infusion of hormones or blood products during hospitalization, except for albumin |
6 | The mother had no history of infection during pregnancy or long-term use of antimicrobials, hormones, or blood products |
7 | While hospitalized, latamoxef was the only acceptable antimicrobial medication, special formula milk for preterm neonates was given, and other nutritional supplementation was administered intravenously |
8 | Full-term infants did not receive any antimicrobial therapies during the hospital stay |
